PS-341 in Treating Patients With Metastatic Kidney Cancer

NCT00017329 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: bortezomib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]